Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia

BACKGROUND: The granulocyte-colony stimulating factor (G-CSF) biosimilar filgrastim (Nivestim™) reduces the duration and severity of neutropenia and the frequency of occurrence of febrile neutropenia (FN). Administration of this biosimilar filgrastim and the patient population receiving it at home h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Patient Prefer Adherence
Autors principals: Otremba, Burkhard, Hielscher, Carsten, Petersen, Volker, Petrik, Christian
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199230/
https://ncbi.nlm.nih.gov/pubmed/30410313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S168029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars